IRIDEX Corporation (IRIX)
USD 0.95
(-7.77%)
USD 0.95
(-7.77%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -10 Million USD | -32.68% |
| 2022 | -7.54 Million USD | -0.12% |
| 2021 | -7.53 Million USD | -14.43% |
| 2020 | -6.58 Million USD | 26.64% |
| 2019 | -8.97 Million USD | 30.26% |
| 2018 | -12.86 Million USD | 0.16% |
| 2017 | -12.88 Million USD | -402.46% |
| 2016 | -2.56 Million USD | -990.63% |
| 2015 | 288 Thousand USD | -88.87% |
| 2014 | 2.58 Million USD | -1.75% |
| 2013 | 2.63 Million USD | 406.16% |
| 2012 | -860 Thousand USD | -144.47% |
| 2011 | 1.93 Million USD | -30.85% |
| 2010 | 2.79 Million USD | 11.08% |
| 2009 | 2.51 Million USD | 133.41% |
| 2008 | -7.53 Million USD | 68.75% |
| 2007 | -24.11 Million USD | -406.09% |
| 2006 | -4.76 Million USD | -363.41% |
| 2005 | 1.8 Million USD | 268.12% |
| 2004 | -1.07 Million USD | -2141.67% |
| 2003 | -48 Thousand USD | 73.48% |
| 2002 | -181 Thousand USD | 90.9% |
| 2001 | -1.98 Million USD | -171.37% |
| 2000 | 2.78 Million USD | 52.71% |
| 1999 | 1.82 Million USD | 1.39% |
| 1998 | 1.8 Million USD | -33.33% |
| 1997 | 2.7 Million USD | 170.0% |
| 1996 | 1 Million USD | -28.57% |
| 1995 | 1.4 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -3.29 Million USD | -6.88% |
| 2024 Q2 | -2.63 Million USD | 19.89% |
| 2023 Q3 | -1.68 Million USD | 41.67% |
| 2023 Q1 | -2.34 Million USD | -66.24% |
| 2023 FY | -10 Million USD | -32.68% |
| 2023 Q4 | -3.08 Million USD | -82.52% |
| 2023 Q2 | -2.89 Million USD | -23.46% |
| 2022 FY | -7.54 Million USD | -0.12% |
| 2022 Q4 | -1.41 Million USD | 16.81% |
| 2022 Q3 | -1.69 Million USD | 21.53% |
| 2022 Q1 | -2.27 Million USD | 5.01% |
| 2022 Q2 | -2.16 Million USD | 5.14% |
| 2021 Q4 | -2.39 Million USD | -11.13% |
| 2021 FY | -7.53 Million USD | -14.43% |
| 2021 Q1 | -1.84 Million USD | -513.67% |
| 2021 Q2 | -1.13 Million USD | 38.19% |
| 2021 Q3 | -2.15 Million USD | -89.54% |
| 2020 Q1 | -1.65 Million USD | -2.23% |
| 2020 Q2 | -2.78 Million USD | -68.42% |
| 2020 Q3 | -1.84 Million USD | 33.69% |
| 2020 Q4 | -300 Thousand USD | 83.75% |
| 2020 FY | -6.58 Million USD | 26.64% |
| 2019 Q2 | -2.46 Million USD | 18.71% |
| 2019 FY | -8.97 Million USD | 30.26% |
| 2019 Q4 | -1.61 Million USD | 12.74% |
| 2019 Q1 | -3.03 Million USD | -4.37% |
| 2019 Q3 | -1.85 Million USD | 24.92% |
| 2018 Q1 | -3.61 Million USD | 30.68% |
| 2018 Q2 | -3.28 Million USD | 9.26% |
| 2018 Q3 | -3.06 Million USD | 6.76% |
| 2018 Q4 | -2.9 Million USD | 4.93% |
| 2018 FY | -12.86 Million USD | 0.16% |
| 2017 Q1 | -1.85 Million USD | -72.68% |
| 2017 Q2 | -2.74 Million USD | -47.52% |
| 2017 Q4 | -5.21 Million USD | -69.91% |
| 2017 Q3 | -3.07 Million USD | -12.04% |
| 2017 FY | -12.88 Million USD | -402.46% |
| 2016 Q1 | 152 Thousand USD | -68.92% |
| 2016 Q2 | -394 Thousand USD | -359.21% |
| 2016 FY | -2.56 Million USD | -990.63% |
| 2016 Q4 | -1.07 Million USD | 13.71% |
| 2016 Q3 | -1.24 Million USD | -216.5% |
| 2015 FY | 288 Thousand USD | -88.87% |
| 2015 Q2 | -747 Thousand USD | -285.36% |
| 2015 Q1 | 403 Thousand USD | -59.04% |
| 2015 Q4 | 489 Thousand USD | 241.96% |
| 2015 Q3 | 143 Thousand USD | 119.14% |
| 2014 FY | 2.58 Million USD | -1.75% |
| 2014 Q1 | 597 Thousand USD | 7.37% |
| 2014 Q2 | 400 Thousand USD | -33.0% |
| 2014 Q3 | 606 Thousand USD | 51.5% |
| 2014 Q4 | 984 Thousand USD | 62.38% |
| 2013 Q4 | 556 Thousand USD | -16.39% |
| 2013 Q3 | 665 Thousand USD | 29.13% |
| 2013 Q2 | 515 Thousand USD | -42.59% |
| 2013 Q1 | 897 Thousand USD | 194.1% |
| 2013 FY | 2.63 Million USD | 406.16% |
| 2012 FY | -860 Thousand USD | -144.47% |
| 2012 Q4 | 305 Thousand USD | 152.68% |
| 2012 Q3 | -579 Thousand USD | -65.43% |
| 2012 Q2 | -350 Thousand USD | -48.31% |
| 2012 Q1 | -236 Thousand USD | -163.61% |
| 2011 Q4 | 371 Thousand USD | -28.1% |
| 2011 Q1 | 612 Thousand USD | -47.87% |
| 2011 Q2 | 435 Thousand USD | -28.92% |
| 2011 FY | 1.93 Million USD | -30.85% |
| 2011 Q3 | 516 Thousand USD | 18.62% |
| 2010 FY | 2.79 Million USD | 11.08% |
| 2010 Q4 | 1.17 Million USD | 32.66% |
| 2010 Q2 | 135 Thousand USD | -77.61% |
| 2010 Q3 | 885 Thousand USD | 555.56% |
| 2010 Q1 | 603 Thousand USD | -23.38% |
| 2009 FY | 2.51 Million USD | 133.41% |
| 2009 Q4 | 787 Thousand USD | -18.78% |
| 2009 Q3 | 969 Thousand USD | 142.86% |
| 2009 Q1 | 363 Thousand USD | 105.75% |
| 2009 Q2 | 399 Thousand USD | 9.92% |
| 2008 Q2 | -256 Thousand USD | 65.31% |
| 2008 Q4 | -6.31 Million USD | -2643.91% |
| 2008 Q3 | -230 Thousand USD | 10.16% |
| 2008 FY | -7.53 Million USD | 68.75% |
| 2008 Q1 | -738 Thousand USD | 95.3% |
| 2007 Q1 | -4.79 Million USD | -145.59% |
| 2007 FY | -24.11 Million USD | -406.09% |
| 2007 Q4 | -15.71 Million USD | -1391.18% |
| 2007 Q3 | -1.05 Million USD | 58.67% |
| 2007 Q2 | -2.55 Million USD | 46.81% |
| 2006 FY | -4.76 Million USD | -363.41% |
| 2006 Q2 | -533 Thousand USD | 25.66% |
| 2006 Q3 | -1.48 Million USD | -179.17% |
| 2006 Q1 | -717 Thousand USD | -203.61% |
| 2006 Q4 | -1.95 Million USD | -31.18% |
| 2005 Q1 | -158 Thousand USD | -153.92% |
| 2005 Q2 | 558 Thousand USD | 453.16% |
| 2005 Q3 | 717 Thousand USD | 28.49% |
| 2005 Q4 | 692 Thousand USD | -3.49% |
| 2005 FY | 1.8 Million USD | 268.12% |
| 2004 FY | -1.07 Million USD | -2141.67% |
| 2004 Q4 | 293 Thousand USD | 120.78% |
| 2004 Q3 | -1.41 Million USD | -1219.05% |
| 2004 Q2 | 126 Thousand USD | 248.24% |
| 2004 Q1 | -85 Thousand USD | -120.88% |
| 2003 Q1 | -176 Thousand USD | -119.95% |
| 2003 Q3 | 212 Thousand USD | 143.18% |
| 2003 Q4 | 407 Thousand USD | 91.98% |
| 2003 Q2 | -491 Thousand USD | -178.98% |
| 2003 FY | -48 Thousand USD | 73.48% |
| 2002 Q2 | -711 Thousand USD | -104.9% |
| 2002 Q1 | -347 Thousand USD | -162.88% |
| 2002 FY | -181 Thousand USD | 90.9% |
| 2002 Q4 | 882 Thousand USD | 17740.0% |
| 2002 Q3 | -5000.00 USD | 99.3% |
| 2001 Q4 | -132 Thousand USD | -1785.71% |
| 2001 Q3 | -7000.00 USD | 93.2% |
| 2001 Q2 | -103 Thousand USD | 94.1% |
| 2001 Q1 | -1.74 Million USD | -710.84% |
| 2001 FY | -1.98 Million USD | -171.37% |
| 2000 FY | 2.78 Million USD | 52.71% |
| 2000 Q4 | 286 Thousand USD | -57.88% |
| 2000 Q3 | 679 Thousand USD | -25.63% |
| 2000 Q2 | 913 Thousand USD | 0.44% |
| 2000 Q1 | 909 Thousand USD | -11.32% |
| 1999 Q1 | 100 Thousand USD | -50.0% |
| 1999 FY | 1.82 Million USD | 1.39% |
| 1999 Q4 | 1.02 Million USD | 156.25% |
| 1999 Q3 | 400 Thousand USD | 0.0% |
| 1999 Q2 | 400 Thousand USD | 300.0% |
| 1998 FY | 1.8 Million USD | -33.33% |
| 1998 Q4 | 200 Thousand USD | 300.0% |
| 1998 Q3 | -100 Thousand USD | -116.67% |
| 1998 Q2 | 600 Thousand USD | -33.33% |
| 1998 Q1 | 900 Thousand USD | -30.77% |
| 1997 Q4 | 1.3 Million USD | 85.71% |
| 1997 FY | 2.7 Million USD | 170.0% |
| 1997 Q2 | 700 Thousand USD | 250.0% |
| 1997 Q1 | 200 Thousand USD | -60.0% |
| 1997 Q3 | 700 Thousand USD | 0.0% |
| 1996 FY | 1 Million USD | -28.57% |
| 1996 Q1 | 2.4 Million USD | 147.06% |
| 1996 Q2 | 200 Thousand USD | -91.67% |
| 1996 Q3 | 100 Thousand USD | -50.0% |
| 1996 Q4 | 500 Thousand USD | 400.0% |
| 1995 FY | 1.4 Million USD | 0.0% |
| 1995 Q3 | 2.1 Million USD | -4.55% |
| 1995 Q4 | -5.1 Million USD | -342.86% |
| 1995 Q1 | 2.1 Million USD | 0.0% |
| 1995 Q2 | 2.2 Million USD | 4.76% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | 30.318% |
| Cerus Corporation | -30.05 Million USD | 66.702% |
| OrthoPediatrics Corp. | -25.76 Million USD | 61.162% |
| PetVivo Holdings, Inc. | -10.62 Million USD | 5.784% |
| Talis Biomedical Corporation | -66.81 Million USD | 85.023% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | 42.143% |
| Inogen, Inc. | -109.38 Million USD | 90.852% |
| Spectral AI, Inc. | -12.98 Million USD | 22.928% |
| Nano-X Imaging Ltd. | -62.58 Million USD | 84.012% |
| CVRx, Inc. | -43.1 Million USD | 76.784% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -183.645% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | 19.48% |
| Orthofix Medical Inc. | -139.11 Million USD | 92.806% |
| Venus Concept Inc. | -28.3 Million USD | 64.651% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | 81.478% |
| Bioventus Inc. | -81.72 Million USD | 87.755% |
| BrainsWay Ltd. | -4.92 Million USD | -103.105% |
| Envoy Medical, Inc. | -18.37 Million USD | 45.528% |
| electroCore, Inc. | -18.8 Million USD | 46.785% |
| IceCure Medical Ltd | -15.57 Million USD | 35.754% |
| Lucid Diagnostics Inc. | -48.48 Million USD | 79.359% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | 42.049% |
| MaxCyte, Inc. | -48.29 Million USD | 79.281% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | 16.296% |
| Nexalin Technology, Inc. | -5.69 Million USD | -75.676% |
| PAVmed Inc | -68.79 Million USD | 85.454% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | 82.308% |
| RxSight, Inc. | -50.08 Million USD | 80.02% |
| Sight Sciences, Inc. | -57.27 Million USD | 82.528% |
| SI-BONE, Inc. | -46.93 Million USD | 78.677% |
| TELA Bio, Inc. | -44.07 Million USD | 77.296% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | 81.52% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | 80.542% |
| LivaNova PLC | -68.49 Million USD | 85.391% |
| 908 Devices Inc. | -42.75 Million USD | 76.596% |
| Alphatec Holdings, Inc. | -173.39 Million USD | 94.229% |
| Nemaura Medical Inc. | -9.59 Million USD | -4.291% |
| NeuroPace, Inc. | -27.17 Million USD | 63.174% |
| LENSAR, Inc. | -12.22 Million USD | 18.17% |
| Apyx Medical Corporation | -17.25 Million USD | 42.019% |
| Cutera, Inc. | -156.23 Million USD | 93.595% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | -16.306% |
| BioSig Technologies, Inc. | -28.51 Million USD | 64.902% |
| Anika Therapeutics, Inc. | -87.63 Million USD | 88.582% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | 55.417% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | 108.973% |
| Axonics, Inc. | -26.05 Million USD | 61.596% |
| Outset Medical, Inc. | -169.77 Million USD | 94.106% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | 90.834% |
| IRadimed Corporation | 20.03 Million USD | 149.946% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -21.371% |
| INVO Bioscience, Inc. | -6.76 Million USD | -47.876% |
| Telesis Bio, Inc. | -35.15 Million USD | 71.531% |
| Viemed Healthcare, Inc. | 14.33 Million USD | 169.833% |
| Varex Imaging Corporation | 32.1 Million USD | 131.174% |
| Quipt Home Medical Corp. | 3.91 Million USD | 355.346% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | 17.522% |
| Pulmonx Corporation | -61.93 Million USD | 83.843% |
| Dynatronics Corporation | -2.27 Million USD | -340.246% |
| Modular Medical, Inc. | -17.52 Million USD | 42.912% |
| ReShape Lifesciences Inc. | -14.63 Million USD | 31.642% |
| Semler Scientific, Inc. | 22.25 Million USD | 144.963% |
| InMode Ltd. | 195.66 Million USD | 105.114% |
| Bruker Corporation | 436.9 Million USD | 102.29% |
| Cytosorbents Corporation | -31.2 Million USD | 67.936% |
| DexCom, Inc. | 597.7 Million USD | 101.674% |
| Align Technology, Inc. | 643.33 Million USD | 101.555% |
| Viveve Medical, Inc. | -21.55 Million USD | 53.57% |
| ZimVie Inc. | -30.93 Million USD | 67.656% |
| Movano Inc. | -29.69 Million USD | 66.295% |
| Cytek Biosciences, Inc. | -27.84 Million USD | 64.062% |
| Nexalin Technology, Inc. | -5.69 Million USD | -75.676% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -183.645% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | 95.709% |
| Profound Medical Corp. | -28.61 Million USD | 65.03% |
| Insulet Corporation | 220 Million USD | 104.549% |
| enVVeno Medical Corporation | -25.23 Million USD | 60.349% |
| Surmodics, Inc. | -5.64 Million USD | -77.272% |
| iCAD, Inc. | -7.68 Million USD | -30.147% |
| Nuwellis, Inc. | -17.63 Million USD | 43.239% |
| Biotricity, Inc. | -8.82 Million USD | -13.352% |
| iRhythm Technologies, Inc. | -125.16 Million USD | 92.005% |
| Aethlon Medical, Inc. | -12.63 Million USD | 20.809% |
| InspireMD, Inc. | -21.14 Million USD | 52.67% |
| PAVmed Inc. | -68.79 Million USD | 85.454% |
| BIOLASE, Inc. | -17.93 Million USD | 44.21% |
| Beyond Air, Inc. | -63 Million USD | 84.117% |
| FONAR Corporation | 16.53 Million USD | 160.519% |
| AxoGen, Inc. | -21.46 Million USD | 53.373% |
| Vivani Medical, Inc. | -26.96 Million USD | 62.889% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | 155.468% |
| Inari Medical, Inc. | -14.03 Million USD | 28.684% |
| UFP Technologies, Inc. | 57.66 Million USD | 117.354% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | -103.081% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | -58.696% |
| Tenon Medical, Inc. | -15.72 Million USD | 36.371% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | -33.891% |
| Co-Diagnostics, Inc. | -42.7 Million USD | 76.568% |
| AdaptHealth Corp. | -598.4 Million USD | 98.328% |
| Sintx Technologies, Inc. | -13.35 Million USD | 25.086% |
| NanoVibronix, Inc. | -3.43 Million USD | -191.24% |
| Quanterix Corporation | -49.7 Million USD | 79.866% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | 17.522% |
| Sensus Healthcare, Inc. | -382 Thousand USD | -2519.634% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 97.008% |
| TransMedics Group, Inc. | -28.72 Million USD | 65.165% |
| ReWalk Robotics Ltd. | -23.61 Million USD | 57.619% |
| NeuroMetrix, Inc. | -7.15 Million USD | -39.928% |
| Hyperfine, Inc. | -48.11 Million USD | 79.202% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | 84.611% |
| Biomerica, Inc. | -6.36 Million USD | -57.17% |
| Bone Biologics Corporation | -9.42 Million USD | -6.138% |
| AVITA Medical, Inc. | -40.4 Million USD | 75.231% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | 2.95% |
| Silk Road Medical, Inc | -59.27 Million USD | 83.117% |